{"transactions":[{"id":4622891,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T20:22:27.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date."}],"balance_after":10000,"derivative":{"exercise_price":95.22,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001202094-26-000009","document":"wk-form4a_1789762944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000120209426000009/wk-form4a_1789762944.xml","form_type":"4/A","original_submission_date":"2026-06-04"}},{"id":4618519,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T21:52:57.000Z","date":"2026-09-15","kind":"sale","planned":false,"acquired":false,"shares":500,"price":105.05,"value":52525.0,"ownership":{"direct":false,"nature":"Kimberly Joan Manhard Revocable Trust,  Dtd 6/4/2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001202094-26-000006","document":"wk-form4_1789509175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000120209426000006/wk-form4_1789509175.xml","form_type":"4"}},{"id":4618518,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T21:52:57.000Z","date":"2026-09-14","kind":"sale","planned":false,"acquired":false,"shares":500,"price":110.26,"value":55130.0,"ownership":{"direct":false,"nature":"Kimberly Joan Manhard Revocable Trust,  Dtd 6/4/2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001202094-26-000006","document":"wk-form4_1789509175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000120209426000006/wk-form4_1789509175.xml","form_type":"4"}},{"id":4618517,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T21:52:57.000Z","date":"2026-09-11","kind":"sale","planned":false,"acquired":false,"shares":500,"price":111.775,"value":55887.5,"ownership":{"direct":false,"nature":"Kimberly Joan Manhard Revocable Trust,  Dtd 6/4/2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001202094-26-000006","document":"wk-form4_1789509175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000120209426000006/wk-form4_1789509175.xml","form_type":"4"}},{"id":4615202,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T23:06:02.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":500,"price":115.795,"value":57897.5,"ownership":{"direct":false,"nature":"Kimberly Joan Manhard Revocable Trust,  Dtd 6/4/2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001202094-26-000004","document":"wk-form4_1789081560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000120209426000004/wk-form4_1789081560.xml","form_type":"4"}},{"id":4615201,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T23:06:02.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":500,"price":115.14,"value":57570.0,"ownership":{"direct":false,"nature":"Kimberly Joan Manhard Revocable Trust,  Dtd 6/4/2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012."}],"balance_after":9500,"source":{"system":"sec-edgar","filing":"0001202094-26-000004","document":"wk-form4_1789081560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000120209426000004/wk-form4_1789081560.xml","form_type":"4"}},{"id":749376,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:28:48.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date."}],"balance_after":15000,"derivative":{"exercise_price":95.22,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001202094-26-000002","document":"wk-form4_1780608525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000120209426000002/wk-form4_1780608525.xml","form_type":"4"}},{"id":1130374,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:35:52.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on May 28, 2026, subject to the reporting person's continued service through such date."}],"balance_after":15000,"derivative":{"exercise_price":12.91,"exercise_date":"2026-05-28","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0002007919-25-000072","document":"wk-form4_1748550943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000200791925000072/wk-form4_1748550943.xml","form_type":"4"}},{"id":1418875,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T20:16:36.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":13.98,"value":139800.0,"ownership":{"direct":false,"nature":"Kimberly Joan Manhard Revocable Trust,  Dtd 6/4/2012"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $13.925 to $14.04, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are directly owned by the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012. Kimberly Manhard is a trustee of the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the  Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0002007919-24-000042","document":"wk-form4_1725048989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000200791924000042/wk-form4_1725048989.xml","form_type":"4"}},{"id":1497633,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:19.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such stock option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on June 23, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":20.43,"expiration_date":"2030-08-20","underlying":"Common Stock","underlying_shares":17259},"source":{"system":"sec-edgar","filing":"0000950142-24-001501","document":"es240484813_4-manhard.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000095014224001501/es240484813_4-manhard.xml","form_type":"4"}},{"id":1497632,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:19.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such stock option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on June 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":24.78,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001501","document":"es240484813_4-manhard.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000095014224001501/es240484813_4-manhard.xml","form_type":"4"}},{"id":1497631,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:19.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such stock option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":12.57,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001501","document":"es240484813_4-manhard.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000095014224001501/es240484813_4-manhard.xml","form_type":"4"}},{"id":1497630,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:19.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such stock option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":23.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001501","document":"es240484813_4-manhard.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000095014224001501/es240484813_4-manhard.xml","form_type":"4"}},{"id":1497629,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:19.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such stock option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on October 2, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":17.44,"expiration_date":"2030-10-02","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950142-24-001501","document":"es240484813_4-manhard.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000095014224001501/es240484813_4-manhard.xml","form_type":"4"}},{"id":1497628,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:11:10.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted following the consummation of the merger of Inhibrx, Inc. with a wholly owned indirect subsidiary of Sanofi."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will be fully exercisable on May 30, 2025, subject to the reporting person's continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":15.86,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950142-24-001494","document":"es240484864_4-manhard.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000095014224001494/es240484864_4-manhard.xml","form_type":"4"}},{"id":1874476,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:08:41.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":15000,"derivative":{"exercise_price":23.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-23-000052","document":"wk-form4_1685477312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000173961423000052/wk-form4_1685477312.xml","form_type":"4"}},{"id":1919223,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:26:14.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":27936,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-024497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024497/doc4.xml","form_type":"4"}},{"id":1919222,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:26:14.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-024497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024497/doc4.xml","form_type":"4"}},{"id":1919221,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-04-17T21:26:14.000Z","date":"2023-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1417,"price":2.88,"value":4080.96,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":28330,"source":{"system":"sec-edgar","filing":"0001209191-23-024497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024497/doc4.xml","form_type":"4"}},{"id":1919220,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-04-17T21:26:14.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":29747,"source":{"system":"sec-edgar","filing":"0001209191-23-024497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024497/doc4.xml","form_type":"4"}},{"id":1919219,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-04-17T21:26:14.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":25183,"source":{"system":"sec-edgar","filing":"0001209191-23-024497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024497/doc4.xml","form_type":"4"}},{"id":2050100,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Performance Stock Units","published_at":"2023-01-20T22:08:24.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":149365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."}],"balance_after":149365,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":149365},"source":{"system":"sec-edgar","filing":"0001209191-23-004299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123004299/doc4.xml","form_type":"4"}},{"id":2054169,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:34:33.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":32500,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-003560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003560/doc4.xml","form_type":"4"}},{"id":2054168,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:34:33.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-003560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003560/doc4.xml","form_type":"4"}},{"id":2054167,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-01-17T22:34:33.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.17,"value":6378.04,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":23933,"source":{"system":"sec-edgar","filing":"0001209191-23-003560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003560/doc4.xml","form_type":"4"}},{"id":2054166,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-01-17T22:34:33.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":25945,"source":{"system":"sec-edgar","filing":"0001209191-23-003560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003560/doc4.xml","form_type":"4"}},{"id":2054165,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-01-17T22:34:33.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":21381,"source":{"system":"sec-edgar","filing":"0001209191-23-003560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003560/doc4.xml","form_type":"4"}},{"id":2054164,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2023-01-17T22:34:33.000Z","date":"2022-10-31","kind":"other","acquired":true,"shares":1655,"price":3.2725,"value":5415.9875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2022."}],"balance_after":20131,"source":{"system":"sec-edgar","filing":"0001209191-23-003560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003560/doc4.xml","form_type":"4"}},{"id":2136679,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:36:02.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":37064,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-053827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053827/doc4.xml","form_type":"4"}},{"id":2136678,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:36:02.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-053827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053827/doc4.xml","form_type":"4"}},{"id":2136677,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-10-17T20:36:02.000Z","date":"2022-10-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.76,"value":7565.12,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":18476,"source":{"system":"sec-edgar","filing":"0001209191-22-053827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053827/doc4.xml","form_type":"4"}},{"id":2136676,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-10-17T20:36:02.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":20488,"source":{"system":"sec-edgar","filing":"0001209191-22-053827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053827/doc4.xml","form_type":"4"}},{"id":2136675,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-10-17T20:36:02.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":15924,"source":{"system":"sec-edgar","filing":"0001209191-22-053827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053827/doc4.xml","form_type":"4"}},{"id":2201574,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-27T22:21:17.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":165961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 8 equal quarterly installments beginning one quarter after the date of grant (07/25/2022)."}],"balance_after":165961,"derivative":{"exercise_price":3.17,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":165961},"source":{"system":"sec-edgar","filing":"0001209191-22-043288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122043288/doc4.xml","form_type":"4"}},{"id":2207287,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:55:01.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":41628,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-042259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042259/doc4.xml","form_type":"4"}},{"id":2207286,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:55:01.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-042259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042259/doc4.xml","form_type":"4"}},{"id":2207285,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-07-15T20:55:01.000Z","date":"2022-07-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.01,"value":6056.12,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":14674,"source":{"system":"sec-edgar","filing":"0001209191-22-042259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042259/doc4.xml","form_type":"4"}},{"id":2207284,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-07-15T20:55:01.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":16686,"source":{"system":"sec-edgar","filing":"0001209191-22-042259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042259/doc4.xml","form_type":"4"}},{"id":2207283,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-07-15T20:55:01.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12122,"source":{"system":"sec-edgar","filing":"0001209191-22-042259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042259/doc4.xml","form_type":"4"}},{"id":2254977,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T20:31:04.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":50759,"derivative":{"exercise_price":12.57,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-22-000061","document":"wf-form4_165359702607100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000173961422000061/wf-form4_165359702607100.xml","form_type":"4"}},{"id":2283013,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-05-04T23:01:26.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":1504,"price":4.7564,"value":7153.6256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of sales prices received was $4.695 to $4.835. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":10872,"source":{"system":"sec-edgar","filing":"0001209191-22-027232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122027232/doc4.xml","form_type":"4"}},{"id":2283012,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-05-04T23:01:26.000Z","date":"2022-04-29","kind":"other","acquired":true,"shares":1504,"price":3.842,"value":5778.368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 29, 2022."}],"balance_after":12376,"source":{"system":"sec-edgar","filing":"0001209191-22-027232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122027232/doc4.xml","form_type":"4"}},{"id":2296644,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:03:08.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":46192,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-024519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024519/doc4.xml","form_type":"4"}},{"id":2296643,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:03:08.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-024519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024519/doc4.xml","form_type":"4"}},{"id":2296642,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-04-15T21:03:08.000Z","date":"2022-04-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":6.07,"value":12212.84,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":10872,"source":{"system":"sec-edgar","filing":"0001209191-22-024519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024519/doc4.xml","form_type":"4"}},{"id":2296641,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-04-15T21:03:08.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12884,"source":{"system":"sec-edgar","filing":"0001209191-22-024519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024519/doc4.xml","form_type":"4"}},{"id":2296640,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-04-15T21:03:08.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":8320,"source":{"system":"sec-edgar","filing":"0001209191-22-024519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024519/doc4.xml","form_type":"4"}},{"id":2435404,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:05:55.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":50756,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-003358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003358/doc4.xml","form_type":"4"}},{"id":2435403,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:05:55.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":13750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-003358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003358/doc4.xml","form_type":"4"}},{"id":2435402,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-01-14T22:05:55.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":8.3,"value":16699.6,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":7070,"source":{"system":"sec-edgar","filing":"0001209191-22-003358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003358/doc4.xml","form_type":"4"}},{"id":2435401,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-01-14T22:05:55.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":9082,"source":{"system":"sec-edgar","filing":"0001209191-22-003358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003358/doc4.xml","form_type":"4"}},{"id":2435400,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2022-01-14T22:05:55.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":4518,"source":{"system":"sec-edgar","filing":"0001209191-22-003358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003358/doc4.xml","form_type":"4"}},{"id":2542006,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:22:38.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":55320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":55320,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":55320},"source":{"system":"sec-edgar","filing":"0001209191-21-060547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060547/doc4.xml","form_type":"4"}},{"id":2542005,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-15T20:22:38.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":92200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant."}],"balance_after":92200,"derivative":{"exercise_price":10.55,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":92200},"source":{"system":"sec-edgar","filing":"0001209191-21-060547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060547/doc4.xml","form_type":"4"}},{"id":2542004,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:22:38.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-060547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060547/doc4.xml","form_type":"4"}},{"id":2542003,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-10-15T20:22:38.000Z","date":"2021-10-13","kind":"tax_withholding","acquired":false,"shares":433,"price":10.55,"value":4568.15,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":3268,"source":{"system":"sec-edgar","filing":"0001209191-21-060547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060547/doc4.xml","form_type":"4"}},{"id":2542002,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-10-15T20:22:38.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":3701,"source":{"system":"sec-edgar","filing":"0001209191-21-060547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060547/doc4.xml","form_type":"4"}},{"id":2633565,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2021-07-15T20:47:00.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":16250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-046786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046786/doc4.xml","form_type":"4"}},{"id":2633564,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-07-15T20:47:00.000Z","date":"2021-07-13","kind":"tax_withholding","acquired":false,"shares":433,"price":13.48,"value":5836.84,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":2451,"source":{"system":"sec-edgar","filing":"0001209191-21-046786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046786/doc4.xml","form_type":"4"}},{"id":2633563,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-07-15T20:47:00.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":2884,"source":{"system":"sec-edgar","filing":"0001209191-21-046786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046786/doc4.xml","form_type":"4"}},{"id":2677193,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-08T21:19:32.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on June 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":35759,"derivative":{"exercise_price":24.78,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-21-000070","document":"wf-form4_162318715271682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000173961421000070/wf-form4_162318715271682.xml","form_type":"4"}},{"id":2731525,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-05-04T22:03:18.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":1529,"price":17.6643,"value":27008.7147,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of sales prices received was $17.46 to $17.84. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":1634,"source":{"system":"sec-edgar","filing":"0001209191-21-030014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121030014/doc4.xml","form_type":"4"}},{"id":2731524,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-05-04T22:03:18.000Z","date":"2021-04-30","kind":"other","acquired":true,"shares":1529,"price":13.8975,"value":21249.2775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021."}],"balance_after":3163,"source":{"system":"sec-edgar","filing":"0001209191-21-030014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121030014/doc4.xml","form_type":"4"}},{"id":2748977,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2021-04-15T20:51:40.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-026841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026841/doc4.xml","form_type":"4"}},{"id":2748976,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-04-15T20:51:40.000Z","date":"2021-04-13","kind":"tax_withholding","acquired":false,"shares":433,"price":16.66,"value":7213.78,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":1634,"source":{"system":"sec-edgar","filing":"0001209191-21-026841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026841/doc4.xml","form_type":"4"}},{"id":2748975,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-04-15T20:51:40.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":2067,"source":{"system":"sec-edgar","filing":"0001209191-21-026841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026841/doc4.xml","form_type":"4"}},{"id":2906632,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2021-01-15T21:25:30.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-003788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003788/doc4.xml","form_type":"4"}},{"id":2906631,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-01-15T21:25:30.000Z","date":"2021-01-13","kind":"tax_withholding","acquired":false,"shares":433,"price":18.16,"value":7863.28,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":817,"source":{"system":"sec-edgar","filing":"0001209191-21-003788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003788/doc4.xml","form_type":"4"}},{"id":2906630,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2021-01-15T21:25:30.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001209191-21-003788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003788/doc4.xml","form_type":"4"}},{"id":2933803,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-23T21:23:50.000Z","date":"2020-12-22","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016)."}],"balance_after":48416,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-065014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065014/doc4.xml","form_type":"4"}},{"id":2933802,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2020-12-23T21:23:50.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":10000,"price":20,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 15, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-065014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065014/doc4.xml","form_type":"4"}},{"id":2933801,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Common Stock","published_at":"2020-12-23T21:23:50.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":10000,"price":13,"value":130000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 15, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-065014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065014/doc4.xml","form_type":"4"}},{"id":3006595,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Restricted Stock Units","published_at":"2020-10-15T20:25:38.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-054909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054909/doc4.xml","form_type":"4"}},{"id":3006594,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-15T20:25:38.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":15.72,"expiration_date":"2030-10-13","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-20-054909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054909/doc4.xml","form_type":"4"}},{"id":3049719,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T20:24:26.000Z","date":"2020-08-21","kind":"grant","acquired":true,"shares":17259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on June 23, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":17259,"derivative":{"exercise_price":17,"expiration_date":"2030-08-20","underlying":"Common Stock","underlying_shares":17259},"source":{"system":"sec-edgar","filing":"0001628280-20-012982","document":"wf-form4_159804145390757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202094/000162828020012982/wf-form4_159804145390757.xml","form_type":"4"}},{"id":3166039,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2020-05-01T22:48:33.000Z","date":"2020-05-01","kind":"sale","acquired":false,"shares":1158,"price":13.9687,"value":16175.7546,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of sales prices received was $13.91 to $14.06. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-026627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120026627/doc4.xml","form_type":"4"}},{"id":3166038,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2020-05-01T22:48:33.000Z","date":"2020-04-30","kind":"other","acquired":true,"shares":1158,"price":12.121,"value":14036.118,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2020."}],"balance_after":1158,"source":{"system":"sec-edgar","filing":"0001209191-20-026627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120026627/doc4.xml","form_type":"4"}},{"id":3333112,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-23T21:28:41.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":25.02,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-19-061795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119061795/doc4.xml","form_type":"4"}},{"id":3355179,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-03T23:30:46.000Z","date":"2019-11-29","kind":"exercise","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016)."}],"balance_after":58416,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-19-058834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119058834/doc4.xml","form_type":"4"}},{"id":3355178,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2019-12-03T23:30:46.000Z","date":"2019-11-29","kind":"sale","acquired":false,"shares":24000,"price":26,"value":624000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 13, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-058834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119058834/doc4.xml","form_type":"4"}},{"id":3355177,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2019-12-03T23:30:46.000Z","date":"2019-11-29","kind":"exercise","acquired":true,"shares":24000,"price":13,"value":312000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 13, 2019."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001209191-19-058834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119058834/doc4.xml","form_type":"4"}},{"id":3543271,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2019-05-03T00:40:53.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":1109,"price":18.8621,"value":20918.0689,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of sales prices received was $18.56 to $19.16. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-027143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119027143/doc4.xml","form_type":"4"}},{"id":3543270,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2019-05-03T00:40:53.000Z","date":"2019-04-30","kind":"other","acquired":true,"shares":1109,"price":18.428,"value":20436.652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2019."}],"balance_after":1109,"source":{"system":"sec-edgar","filing":"0001209191-19-027143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119027143/doc4.xml","form_type":"4"}},{"id":3728049,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-19T01:08:19.000Z","date":"2018-12-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":24.97,"expiration_date":"2028-12-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-063350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118063350/doc4.xml","form_type":"4"}},{"id":3777465,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-11-03T01:17:08.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":494,"price":30.6173,"value":15124.9462,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of sales prices received was $30.34 to $30.89. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-057056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118057056/doc4.xml","form_type":"4"}},{"id":3777464,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-11-03T01:17:08.000Z","date":"2018-10-31","kind":"other","acquired":true,"shares":494,"price":23.596,"value":11656.424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2018."}],"balance_after":494,"source":{"system":"sec-edgar","filing":"0001209191-18-057056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118057056/doc4.xml","form_type":"4"}},{"id":3803251,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T01:12:13.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016)."}],"balance_after":82416,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-053532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118053532/doc4.xml","form_type":"4"}},{"id":3803250,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-10-03T01:12:13.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":6000,"price":32.0722,"value":192433.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $31.75 to $32.38. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-053532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118053532/doc4.xml","form_type":"4"}},{"id":3803249,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-10-03T01:12:13.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":6000,"price":13,"value":78000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-18-053532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118053532/doc4.xml","form_type":"4"}},{"id":3877239,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-04T01:05:49.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016)."}],"balance_after":88416,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-041386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041386/doc4.xml","form_type":"4"}},{"id":3877238,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-07-04T01:05:49.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":100,"price":38.85,"value":3885.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-041386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041386/doc4.xml","form_type":"4"}},{"id":3877237,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-07-04T01:05:49.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":5900,"price":37.5074,"value":221293.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $37.70 to $38.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-18-041386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041386/doc4.xml","form_type":"4"}},{"id":3877236,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-07-04T01:05:49.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":6000,"price":13,"value":78000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 23, 2018."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-18-041386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041386/doc4.xml","form_type":"4"}},{"id":3990854,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-19T23:24:16.000Z","date":"2018-03-19","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in March 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016)."}],"balance_after":94416,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-18-020737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118020737/doc4.xml","form_type":"4"}},{"id":3990853,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-03-19T23:24:16.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":18000,"price":30,"value":540000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in March 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-020737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118020737/doc4.xml","form_type":"4"}},{"id":3990852,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-03-19T23:24:16.000Z","date":"2018-03-19","kind":"exercise","acquired":true,"shares":18000,"price":13,"value":234000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in March 2017."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-18-020737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118020737/doc4.xml","form_type":"4"}},{"id":4100972,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-12T21:21:27.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":7584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in March 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/21/2016)."}],"balance_after":112416,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":7584},"source":{"system":"sec-edgar","filing":"0001209191-18-003425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118003425/doc4.xml","form_type":"4"}},{"id":4100971,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-01-12T21:21:27.000Z","date":"2018-01-10","kind":"sale","acquired":false,"shares":7584,"price":20,"value":151680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in March 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-003425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118003425/doc4.xml","form_type":"4"}},{"id":4100970,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Common Stock","published_at":"2018-01-12T21:21:27.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":7584,"price":13,"value":98592.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in March 2017."}],"balance_after":7584,"source":{"system":"sec-edgar","filing":"0001209191-18-003425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118003425/doc4.xml","form_type":"4"}},{"id":4125514,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":41279,"kind":"person","name":"MANHARD KIMBERLY","position":1,"cik":"0001202094","reported_name":"MANHARD KIMBERLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Drug Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-20T21:14:32.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":17,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-17-066626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117066626/doc4.xml","form_type":"4"}}],"next_cursor":"2017-12-20T21:14:32.000000Z,4125514"}